The drugs we deserve [2] (multiple letters)

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 111, Issue 4, 2004, Pages 392-393

  Jones, Bryony ^a   Mohan, Aarthi ^a   Bennett, Phillip ^b   Thornton, Jim ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^c Qu Charlottes and Chelsea Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

ATOSIBAN; CORTICOSTEROID; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; ARGIPRESTOCIN; DRUG DERIVATIVE; UTERUS SPASMOLYTIC AGENT;

CLINICAL MEDICINE; DRUG APPROVAL; DRUG CHOICE; FETUS OUTCOME; HUMAN; LEGAL LIABILITY; LETTER; NEWBORN MORTALITY; PREMATURE LABOR; PRIORITY JOURNAL; UNITED KINGDOM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DESIGN; LABOR INDUCTION; NOTE; RANDOMIZED CONTROLLED TRIAL;

DRUG DESIGN; HUMANS; LABOR, INDUCED; RANDOMIZED CONTROLLED TRIALS; TOCOLYTIC AGENTS; VASOTOCIN;

EID: 1842422285     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00118.x     Document Type: Letter

References (0)